Varian announced its new single-room proton therapy system, ProBeam 360°, at the 2018 American Society of Radiation Oncology (ASTRO) annual meeting, Oct. 21-24 in San Antonio, Texas. With a 30 percent smaller footprint than the previous system, ProBeam 360° offers uncompromised clinical capabilities, according to Varian, while reducing vault construction costs by approximately 25 percent. The new system has a 360-degree rotating gantry, a powerful particle accelerator, iterative cone-beam computed tomography (CBCT) imaging and high-definition pencil-beam scanning technology. The system can also provide clinicians a viable path to potential next-generation treatments such as Flash therapy.
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease risk assessment, according to a new study appearing in the journal Radiology.
With its shorter course of treatment, stereotactic body radiation therapy (SBRT) has long been preferred for patients ...
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
Whole-brain radiotherapy can be delivered more safely to patients with brain metastases by avoiding the hippocampus, according to a randomized phase III NRG Oncology trial. Trial results were presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting, Oct. 21-24 in San Antonio, Texas.
Artificial intelligence (AI) will not force specialists in radiation oncology from their jobs but rather make them ...

SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
The first report of a large, international clinical trial shows that, for men who show signs of prostate cancer after ...
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
Treatment of renal cell carcinoma with stereotactic radiation therapy is as safe and effective for patients with one ...
In a 10-year study of women who received radiation therapy to treat early-stage breast cancer, those receiving fewer ...
Efficiency is the root of value-based medicine. Efficiency boosts productivity, as it lowers cost and increases patient ...
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
Adding radiation therapy or surgery to systemic therapy for stage IV lung cancer patients whose cancer has spread to a ...
A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation ...
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S. regulators do as expected ...
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
October 19, 2018 – At the 2018 American Society of Radiation Oncology (ASTRO) annual meeting in San Antonio, Texas, Oct ...
October 19, 2018 – IBA (Ion Beam Applications S.A.) is sharing how hospitals can secure performance, investment and ...
Scott Schwartz, M.D., interventional radiologist and program director for IR residencies and the vascular and ...
At the 60th annual meeting of the American Society for Radiation Oncology (ASTRO), Oct. 21-24 at the Henry B. Gonzalez ...
myQA Daily from IBA Dosimetry enables fast as well as high-quality daily linac QA. More measurement points allow more ...
October 17, 2018 — Nanosonics announced the commercial availability of its Trophon2 high level disinfection (HLD) system ...
IBA (Ion Beam Applications S.A.) announced it has entered into an agreement with Varian with the goal of validating the Dolphin transmission detector for online monitoring of patient treatment.
Boston Scientific Corp. announced the close of its acquisition of Augmenix Inc., developer of the SpaceOAR Hydrogel System to help reduce common and debilitating side effects that men may experience after receiving radiotherapy to treat prostate cancer. The biodegradable SpaceOAR hydrogel is injected between the rectum and prostate to decrease a patient's exposure to rectal radiation and thereby reduce rectal radiation injury – one of the most common complications of prostate radiotherapy.